Orchard Therapeutics' Series B Round

Orchard Therapeutics raised a round of funding on December 20, 2017.

Orchard Therapeutics is a biotechnology company focused on the development and commercialization of transformative ex-vivo gene therapies for patients with orphan diseases. Orchard's development progr…

Articles about Orchard Therapeutics' Series B Round: